clinical and biological subtyping in parkinson’s disease
Published 2 years ago • 75 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
3:04
the complexities of parkinson’s disease subtyping
-
2:13
genetic subtyping in parkinson’s disease
-
1:10
identifying parkinson’s disease therapies: defining subtypes
-
2:21
what have clinical trials taught us about parkinson's disease?
-
1:43
the biological definition of parkinson's disease
-
2:44
biological subtyping: the future of neurodegenerative diseases
-
1:40
highlights in parkinson's disease: subtyping & prodrome
-
1:40
how should patients with parkinson’s be subcategorized?
-
2:00
genetic biomarkers could aid parkinson’s disease diagnosis and guide treatment decisions
-
1:29
how should parkinson’s disease subpopulations be defined?
-
7:46
biological basis of parkinson's disease | behavior | mcat | khan academy
-
3:24
unraveling subtypes of parkinson's disease: a focus on biomarkers
-
2:27
urgent need for biological subtyping in pd to rescue failing trials
-
1:21
the rising utility of genetic testing in parkinson’s disease
-
4:27
markers for the preclinical and prodromal stages of parkinson’s disease
-
9:12
brain-first and body-first parkinson’s disease: are there subgroups of prodromal patients?
-
3:06
the future of gene targeting in treating parkinson’s disease
-
1:12
parkinson's disease - an osmosis preview
-
1:15
mds task force on the biological definition of parkinson's disease